Markedly Elevated CA125 in Hepatic Cirrhosis
- 1 March 1999
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Gastroenterology
- Vol. 28 (2), 159-161
- https://doi.org/10.1097/00004836-199903000-00016
Abstract
CA125 is the most widely used tumor marker presently available for use in patients with epithelial ovarian cancer. Although elevated in a high percentage of patients with ovarian cancer, serum CA125 levels have also been detected in patients with numerous benign and malignant nongynecologic disorders, including various diseases of the liver. Despite this well-publicized fact, it has become apparent that the association between CA125 elevation, particularly the degree of elevation, and liver disease may not be as widely recognized as one would suspect. When marked CA125 elevations occur, diagnostic confusion is common. We describe two cases illustrative of this point. Both cases involve middle-aged women who presented with massive ascites and due to markedly elevated serum CA125 levels underwent exploratory laparotomy with hysterectomy and/or bilateral salpingo-oopherectomy before their referral to our center. Because preservation of a woman's reproductive organs is a significant concern, it is imperative that both primary care physicians and specialists are aware of such associations and the proper use of tumor markers.Keywords
This publication has 9 references indexed in Scilit:
- Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre‐operative diagnosis of pelvic massesBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Activation of Kupffer cells by a single exposure to hyperbaric oxygen in ratsJournal of Hepatology, 1995
- CA 125 serum levels in patients with non-neoplastic liver diseases. A clinical and laboratory studyScandinavian Journal of Clinical and Laboratory Investigation, 1992
- Serum CA125 level is a good prognostic indicator in lung cancerBritish Journal of Cancer, 1990
- Elevation of CA 125 in patients with benign and malignant ascitesCancer, 1987
- Tumour marker antigen CA125 in pancreatic cancer: A comparison with CA19-9 and CEABritish Journal of Cancer, 1986
- Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive SystemThe American Journal of the Medical Sciences, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerThe New England Journal of Medicine, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983